BRIGHTHOUSE FINANCIAL INC (BHF)

US10922N1037 - Common Stock

48.09  +0.1 (+0.21%)

After market: 48.09 0 (0%)

Fundamental Rating

3

Overall BHF gets a fundamental rating of 3 out of 10. We evaluated BHF against 140 industry peers in the Insurance industry. Both the profitability and financial health of BHF have multiple concerns. BHF has a correct valuation and a medium growth rate.



1

1. Profitability

1.1 Basic Checks

BHF had positive earnings in the past year.
BHF had a negative operating cash flow in the past year.
In the past 5 years BHF always reported negative net income.
In multiple years BHF reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -0.53%, BHF is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
BHF's Return On Equity of -23.57% is on the low side compared to the rest of the industry. BHF is outperformed by 92.03% of its industry peers.
Industry RankSector Rank
ROA -0.53%
ROE -23.57%
ROIC N/A
ROA(3y)-0.21%
ROA(5y)-0.28%
ROE(3y)-9.19%
ROE(5y)-7.68%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BHF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BHF has less shares outstanding
Compared to 5 years ago, BHF has less shares outstanding
The debt/assets ratio for BHF has been reduced compared to a year ago.

2.2 Solvency

A Debt/Equity ratio of 0.57 indicates that BHF is somewhat dependend on debt financing.
BHF has a worse Debt to Equity ratio (0.57) than 76.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.77% over the past year.
The Earnings Per Share has been growing by 13.38% on average over the past years. This is quite good.
BHF shows a strong growth in Revenue. In the last year, the Revenue has grown by 55.12%.
BHF shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.41% yearly.
EPS 1Y (TTM)71.77%
EPS 3YN/A
EPS 5Y13.38%
EPS Q2Q%200.96%
Revenue 1Y (TTM)55.12%
Revenue growth 3Y-21.48%
Revenue growth 5Y-14.41%
Sales Q2Q%5.24%

3.2 Future

BHF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.69% yearly.
BHF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.33% yearly.
EPS Next Y42.4%
EPS Next 2Y20.27%
EPS Next 3Y17.44%
EPS Next 5Y17.69%
Revenue Next Year4.09%
Revenue Next 2Y4.19%
Revenue Next 3Y3.58%
Revenue Next 5Y4.33%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 1.91 indicates a rather cheap valuation of BHF.
Compared to the rest of the industry, the Price/Earnings ratio of BHF indicates a rather cheap valuation: BHF is cheaper than 89.13% of the companies listed in the same industry.
BHF's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
A Price/Forward Earnings ratio of 2.39 indicates a rather cheap valuation of BHF.
85.51% of the companies in the same industry are more expensive than BHF, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.69. BHF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 1.91
Fwd PE 2.39

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BHF's earnings are expected to grow with 17.44% in the coming years.
PEG (NY)0.05
PEG (5Y)0.14
EPS Next 2Y20.27%
EPS Next 3Y17.44%

0

5. Dividend

5.1 Amount

BHF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTHOUSE FINANCIAL INC

NASDAQ:BHF (1/3/2025, 8:22:22 PM)

After market: 48.09 0 (0%)

48.09

+0.1 (+0.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-10 2025-02-10/amc
Inst Owners82.99%
Inst Owner Change-3.72%
Ins Owners1.06%
Ins Owner Change-14.8%
Market Cap2.85B
Analysts51.76
Price Target53.33 (10.9%)
Short Float %2.38%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-7.83%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.44%
Min EPS beat(2)26.1%
Max EPS beat(2)176.78%
EPS beat(4)3
Avg EPS beat(4)46.22%
Min EPS beat(4)-26.72%
Max EPS beat(4)176.78%
EPS beat(8)6
Avg EPS beat(8)30.64%
EPS beat(12)9
Avg EPS beat(12)17.51%
EPS beat(16)12
Avg EPS beat(16)23.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.16%
Min Revenue beat(2)-3.47%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-2.74%
Min Revenue beat(4)-5.91%
Max Revenue beat(4)-0.74%
Revenue beat(8)1
Avg Revenue beat(8)-12.2%
Revenue beat(12)2
Avg Revenue beat(12)-5.81%
Revenue beat(16)3
Avg Revenue beat(16)-14.34%
PT rev (1m)3.1%
PT rev (3m)14.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.81%
EPS NY rev (1m)-1.1%
EPS NY rev (3m)22.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE 1.91
Fwd PE 2.39
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)25.13
EY52.26%
EPS(NY)20.11
Fwd EY41.81%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS82.88
BVpS93.09
TBVpS93.09
PEG (NY)0.05
PEG (5Y)0.14
Profitability
Industry RankSector Rank
ROA -0.53%
ROE -23.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.21%
ROA(5y)-0.28%
ROE(3y)-9.19%
ROE(5y)-7.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.77%
EPS 3YN/A
EPS 5Y13.38%
EPS Q2Q%200.96%
EPS Next Y42.4%
EPS Next 2Y20.27%
EPS Next 3Y17.44%
EPS Next 5Y17.69%
Revenue 1Y (TTM)55.12%
Revenue growth 3Y-21.48%
Revenue growth 5Y-14.41%
Sales Q2Q%5.24%
Revenue Next Year4.09%
Revenue Next 2Y4.19%
Revenue Next 3Y3.58%
Revenue Next 5Y4.33%
EBIT growth 1Y2.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.17%
EBIT Next 3Y9.92%
EBIT Next 5YN/A
FCF growth 1Y97.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y97.78%
OCF growth 3YN/A
OCF growth 5YN/A